Ingevity Corp (NGVT) stock
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3076% above fair value
$59.28−0.74 (-1.23%)
Close on Nov 17, 2026Market cap $2.04BP/E 40.3Yield –
Ingevity price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Ingevity's price to sales ratio was 1.9× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.8× to 2.3×, with a median of 1.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.9× | +0.1 |
| 2025 | Dec 31, 2025 | 1.8× | +0.8 |
| 2024 | Dec 31, 2024 | 1.0× | +0.0 |
| 2023 | Dec 29, 2023 | 1.0× | −0.6 |
| 2022 | Dec 30, 2022 | 1.6× | −0.4 |
| 2021 | Dec 31, 2021 | 2.0× | −0.6 |
| 2020 | Dec 31, 2020 | 2.6× | −0.3 |
| 2019 | Dec 31, 2019 | 2.9× | −0.4 |
| 2018 | Dec 31, 2018 | 3.2× | +0.1 |
| 2017 | Dec 29, 2017 | 3.1× | +0.6 |
| 2016 | Dec 30, 2016 | 2.5× | – |
See a number that looks wrong?